Pharma Equity Group A/S PEG.CO
Nasdaq Copenhagen · Healthcare · Biotechnology
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Healthcare on Nasdaq Copenhagen
21 stocks in the sector. Pharma Equity Group ranks 16 of 19.
The sector ranking compares the stocks with each other only: each one's quality, value and momentum scores become its place among the sector's stocks from 0 (worst) to 100 (best), and the ranking is by their average. Sign in to add the upside to the target price to the ranking.
Quality against value
Up is higher quality, right is cheaper. The size of a bubble is the market value.
Sector ranking
The average of the parts, 0 to 100.
All stocks in the sector
| # | Company | Sector score | Quality | Value | Momentum | Upside to target | P/E | ROE | Div. yield | 1 year | Guidance met | Market cap (M) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | H. Lundbeck HLUN-A.CO | 79 | 65 | 59 | 90 | 🔒 | 16.0 | 12.8% | 2.2% | +46.1% | – | 51,195 |
| 2 | Bavarian Nordic BAVA.CO | 76 | 76 | 57 | 70 | 🔒 | 13.7 | 10.7% | 0.0% | +0.8% | – | 18,863 |
| 3 | Novo Nordisk NOVO-B.CO | 74 | 83 | 61 | 26 | 🔒 | 11.7 | 52.8% | 4.3% | −10.7% | – | 1,197,296 |
| 4 | H. Lundbeck HLUN-B.CO | 73 | 65 | 54 | 81 | 🔒 | 17.4 | 12.8% | 2.1% | +22.4% | – | 55,560 |
| 5 | Zealand Pharma ZEAL.CO | 70 | 95 | 75 | 5 | 🔒 | 2.5 | 43.5% | 0.0% | −54.6% | – | 16,444 |
| 6 | Gubra GUBRA.CO | 66 | 90 | 61 | 13 | 🔒 | 2.9 | 147.5% | 0.0% | −29.6% | – | 4,939 |
| 7 | GN Store Nord GN.CO | 61 | 36 | 40 | 75 | 🔒 | 27.6 | 6.0% | 0.0% | +9.0% | – | 18,005 |
| 8 | ALK-Abelló ALK-B.CO | 58 | 79 | 21 | 64 | 🔒 | 44.9 | 18.6% | 0.7% | +14.6% | – | 53,795 |
| 9 | Genmab GMAB.CO | 58 | 65 | 17 | 82 | 🔒 | 33.6 | 16.5% | 0.0% | +91.9% | – | 217,261 |
| 10 | ChemoMetec CHEMM.CO | 56 | 92 | 11 | 59 | 🔒 | 60.5 | 27.8% | 0.0% | −10.8% | – | 12,212 |
| 11 | Demant DEMANT.CO | 54 | 52 | 15 | 95 | 🔒 | 51.5 | 15.7% | 0.0% | +75.1% | – | 79,551 |
| 12 | Embla Medical hf. EMBLA.CO | 50 | 52 | 37 | 31 | 🔒 | 21.4 | 9.4% | 0.0% | −16.6% | – | 11,956 |
| 13 | Strategic Partners STRAP.CO | 41 | 9 | 47 | 18 | 🔒 | – | −4.7% | 0.0% | −38.0% | – | 24 |
| 14 | Monsenso MONSO.CO | 37 | 4 | 34 | 45 | 🔒 | – | −103.5% | 0.0% | +83.3% | – | 15 |
| 15 | Scandinavian Medical Solutions SMSMED.CO | 37 | 20 | 35 | 13 | 🔒 | 2,960.4 | 0.0% | 0.0% | −34.6% | – | 77 |
| 16 | Pharma Equity Group PEG.CO | 33 | – | 25 | 13 | 🔒 | – | −99.7% | 0.0% | −34.6% | – | 86 |
| 17 | Stenocare STENO.CO | 25 | 10 | 26 | 4 | 🔒 | – | −25.2% | 0.0% | −55.7% | – | 29 |
| 18 | BioPorto BIOPOR.CO | 22 | 2 | 17 | 26 | 🔒 | – | −130.3% | 0.0% | −21.9% | – | 490 |
| 19 | ViroGates VIRO.CO | 21 | 7 | 24 | 6 | 🔒 | – | −53.6% | 0.0% | −41.6% | – | 72 |
| – | Ambu AMBU-B.CO | – | – | – | 53 | 🔒 | – | – | 0.5% | −12.6% | – | – |
| – | Coloplast COLO-B.CO | – | – | – | 50 | 🔒 | – | – | 4.5% | −9.3% | – | – |
Click a heading to sort. Market cap in millions of DKK. Not investment advice. Compare the share prices →
Not investment advice. Figures may contain errors from the data source.